Home > Antibodies

Classified by application

All Products

Signaling Pathways

Research Areas

Intermediate

Nature products

Antibodies

Peptides

Catalysts

Raw Materials

Impurities

Antibodies

Chemical Structure Cat. No. Product Name CAS No.
Rituximab Chemical Structure
BCP20918 Rituximab 174722-31-7
Rituximab is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of immune system B cells.
Avastin Chemical Structure
BCP07998 Avastin 216974-75-3
Denosumab Chemical Structure
BCP05825 Denosumab 615258-40-7
Denosumab is a human monoclonal antibody for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.
Trastuzumab Chemical Structure
BCP05130 Trastuzumab 180288-69-1
Trastuzumab is a monoclonal antibody used to treat breast cancer.
Cetuximab Chemical Structure
BCP02158 Cetuximab 205923-56-4
Cetuximab is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer.
Ofatumumab Chemical Structure
BCP28064 Ofatumumab 679818-59-8
Ofatumumab is a fully human monoclonal antibody (for the CD20 protein) which appears to inhibit early-stage B lymphocyte activation.
Ranibizumab Chemical Structure
BCP12860 Ranibizumab 347396-82-1
Ranibizumab is a monoclonal antibody fragment (Fab) created from the same parent mouse antibody as bevacizumab.
Nivolumab Chemical Structure
BCP28580 Nivolumab 946414-94-4
Nivolumab, marketed as Opdivo, is a humanized IgG4 anti-PD-1 monoclonal antibody used to treat cancer.
Solanezumab Chemical Structure
BCP13788 Solanezumab 955085-14-0
Solanezumab is a monoclonal antibody being investigated by Eli Lilly as a neuroprotector for patients with Alzheimer's disease.
Atezolizumab Chemical Structure
BCP18055 Atezolizumab 1380723-44-3
Atezolizumab is a fully humanized, engineered monoclonal antibody of IgG1 isotype against the protein programmed cell death-ligand 1 (PD-L1).
123下一页共 24 条记录 1 / 3 页